Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon‐like peptide‐1 receptor agonists

AIMS/INTRODUCTION: Research has proved a correlation between glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and gastrointestinal adverse events. Predominantly, nausea and vomiting are frequent gastrointestinal adverse events that lead to the discontinuation of GLP‐1 RAs treatment. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiomi, Megumi, Takada, Tesshu, Tanaka, Yoichi, Yajima, Keiko, Isomoto, Akira, Sakamoto, Masaki, Otori, Katsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400150/
https://www.ncbi.nlm.nih.gov/pubmed/30033675
http://dx.doi.org/10.1111/jdi.12900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400150/
https://www.ncbi.nlm.nih.gov/pubmed/30033675
http://dx.doi.org/10.1111/jdi.12900

Ejemplares similares